Diet Advice for Crohn's Disease: FODMAP and Beyond.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
06 Dec 2020
Historique:
received: 17 11 2020
accepted: 29 11 2020
entrez: 9 12 2020
pubmed: 10 12 2020
medline: 24 4 2021
Statut: epublish

Résumé

Crohn's disease (CD) is a chronic, progressive, and destructive granulomatous inflammatory bowel disorder that can involve any part of the gastrointestinal tract. It has been presumed that different types of diet might improve gastrointestinal symptoms in CD patients. The aim of this review was to clarify the efficiency and indications of a low-"fermentable oligo-, di-, mono-saccharides and polyols" (FODMAP) diet (LFD) in CD and to further analyze the available data on other types of diets. PubMed, Cochrane Library, EMBASE and WILEY databases were screened for relevant publications regarding the effect of FODMAP diets on CD. Our search identified 12 articles analyzing the effect of an LFD in CD, 5 articles analyzing the effect of a Mediterranean diet (MD), 2 articles analyzing the effect of a vegetarian diet (VD), and 2 articles analyzing the effect of a low-lactose diet (LLD). The majority of the studies included in this review show the significant efficiency of the LFD in CD patients. We found significant evidence demonstrating that the LFD has a favorable impact on gastrointestinal symptoms in CD patients. Notwithstanding the evidence, it remains to be established if an LFD is more efficient than other types of diets in the short term and especially in the long term.

Identifiants

pubmed: 33291329
pii: nu12123751
doi: 10.3390/nu12123751
pmc: PMC7762196
pii:
doi:

Substances chimiques

Polymers 0
polyol 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

J Crohns Colitis. 2009 Feb;3(1):8-14
pubmed: 21172242
J Med Food. 2018 Jul;21(7):633-640
pubmed: 29328869
Neurogastroenterol Motil. 2019 Oct;31(10):e13675
pubmed: 31290223
Gut. 2011 Jul;60(7):923-9
pubmed: 21262918
World J Gastroenterol. 2016 Feb 21;22(7):2179-94
pubmed: 26900283
J Gastroenterol Hepatol. 2010 Aug;25(8):1366-73
pubmed: 20659225
Gastroenterology. 2007 Jan;132(1):397-414
pubmed: 17241888
J Gastroenterol Hepatol. 2010 Feb;25(2):252-8
pubmed: 20136989
Gastroenterology. 2020 Jan;158(1):176-188.e7
pubmed: 31586453
Aliment Pharmacol Ther. 2010 Apr;31(8):874-82
pubmed: 20102355
Inflamm Bowel Dis. 2016 May;22(5):1129-36
pubmed: 26914438
J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:23-26
pubmed: 28244661
Nutrients. 2020 Jan 04;12(1):
pubmed: 31947991
Gastroenterology. 2004 May;126(6):1504-17
pubmed: 15168363
Aliment Pharmacol Ther. 2005 Jun 15;21(12):1399-409
pubmed: 15948806
Gastroenterol Hepatol (N Y). 2017 Jan;13(1):36-45
pubmed: 28420945
Therap Adv Gastroenterol. 2013 May;6(3):231-42
pubmed: 23634187
World J Gastroenterol. 2010 May 28;16(20):2484-95
pubmed: 20503448
JGH Open. 2018 Feb 05;2(1):15-20
pubmed: 30483557
J Clin Gastroenterol. 2016 Nov/Dec;50(10):803-818
pubmed: 27741097
Aliment Pharmacol Ther. 2020 May;51(10):935-947
pubmed: 32249975
Frontline Gastroenterol. 2012 Jul;3(3):172-179
pubmed: 28839660
Gastroenterol Clin North Am. 2017 Dec;46(4):745-767
pubmed: 29173519
J Clin Gastroenterol. 2014 May-Jun;48(5):393-4
pubmed: 24705090
J Hum Nutr Diet. 2011 Oct;24(5):487-95
pubmed: 21615553
J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:5-7
pubmed: 28244673
Am J Gastroenterol. 2017 Feb;112(2):241-258
pubmed: 28071656
Neurogastroenterol Motil. 2017 Apr;29(4):
pubmed: 27747984
Sci Rep. 2020 Apr 27;10(1):7033
pubmed: 32341416
J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:40-42
pubmed: 28244679
Gut. 2006 Mar;55(3):348-55
pubmed: 16162680
Nutrients. 2020 Mar 29;12(4):
pubmed: 32235316
Aliment Pharmacol Ther. 2004 Sep 1;20(5):483-96
pubmed: 15339320
Gut. 2006 Mar;55 Suppl 1:i16-35
pubmed: 16481629
World J Gastroenterol. 2017 Mar 28;23(12):2124-2140
pubmed: 28405140
J Clin Invest. 2018 Jan 2;128(1):267-280
pubmed: 29202473
Curr Treat Options Gastroenterol. 2019 Dec;17(4):564-576
pubmed: 31705371
AMA J Ethics. 2018 Nov 1;20(11):E1025-1032
pubmed: 30499430
Gut. 1970 Apr;11(4):338-43
pubmed: 5468136
Nutrients. 2018 Nov 14;10(11):
pubmed: 30441814
Gut. 1986 Oct;27(10):1161-8
pubmed: 3781328
Curr Treat Options Gastroenterol. 2019 Jun;17(2):313-325
pubmed: 30968340
Dig Liver Dis. 2013 Apr;45(4):269-76
pubmed: 23010518
Hum Genomics. 2013 Nov 27;7:24
pubmed: 24283712
Am J Clin Nutr. 1988 Dec;48(6):1424-30
pubmed: 3202090
Inflamm Bowel Dis. 2021 Jan 1;27(1):1-9
pubmed: 32440680
Clin Transl Gastroenterol. 2016 Apr 14;7:e164
pubmed: 27077959
Crit Rev Food Sci Nutr. 2016 Jun 10;56(8):1370-8
pubmed: 25569442
Inflamm Bowel Dis. 2007 Dec;13(12):1522-8
pubmed: 17828776
Inflamm Bowel Dis. 2014 Jul;20(7):1194-7
pubmed: 24865778
J Am Diet Assoc. 2010 Oct;110(10):1469-76
pubmed: 20869485
J Neurogastroenterol Motil. 2015 Oct 1;21(4):459-70
pubmed: 26350937
Eur J Gastroenterol Hepatol. 2000 Jan;12(1):5-11
pubmed: 10656203
J Crohns Colitis. 2017 Dec 4;11(12):1420-1429
pubmed: 28525543
Pharmacol Ther. 2016 Aug;164:144-51
pubmed: 27113407
Scand J Gastroenterol. 2018 May;53(5):573-578
pubmed: 29168412
United European Gastroenterol J. 2019 Jul;7(6):767-781
pubmed: 31316781
Gastroenterology. 2012 Jan;142(1):46-54.e42; quiz e30
pubmed: 22001864
Gastroenterology. 2007 Nov;133(5):1670-89
pubmed: 17983810
Am J Gastroenterol. 2014 Jan;109(1):110-9
pubmed: 24247211
Gut. 2020 Sep;69(9):1637-1644
pubmed: 31900290
Inflamm Bowel Dis. 2015 Apr;21(4):847-53
pubmed: 25719528
Appl Environ Microbiol. 2011 Mar;77(6):2071-80
pubmed: 21257804
Eur J Nutr. 2020 Apr;59(3):1115-1121
pubmed: 31006053
BMJ Clin Evid. 2011 Apr 27;2011:
pubmed: 21524318

Auteurs

Stefan L Popa (SL)

2nd Medical Department, Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania.

Cristina Pop (C)

Department of Pharmacology, Physiology, and Pathophysiology, Faculty of Pharmacy, Iuliu Hatieganu University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.

Dan L Dumitrascu (DL)

2nd Medical Department, Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH